Bryan J. Schneider

Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

Julie R. Brahmer, Christina Lacchetti, Bryan J. Schneider et al. · Journal of Clinical Oncology · 2018 · 3.7K citations · Full text

Life Sciences, Immunology, Oncology +17

Chemotherapy Use, Performance Status, and Quality of Life at the End of Life

Holly G. Prigerson, Yuhua Bao, Manish A. Shah et al. · JAMA Oncology · 2015 · 651 citations · Full text

Medicine, Oncology, Chemotherapy +15

Systemic Therapy for Stage IV Non–Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update

Nasser H. Hanna, David H. Johnson, Sarah Temin et al. · Journal of Clinical Oncology · 2017 · 650 citations

Medicine, Oncology, Chemotherapy +12

Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology

John A. Thompson, Bryan J. Schneider, Julie R. Brahmer et al. · Journal of the National Comprehensive Cancer Network · 2019 · 560 citations · Full text

Medicine, Oncology, Oncology Nursing +17

NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020

John A. Thompson, Bryan J. Schneider, Julie R. Brahmer et al. · Journal of the National Comprehensive Cancer Network · 2020 · 486 citations · Full text

Medicine, Immunology, Oncology +17